Breaking News
Investing Pro 0
🙌 It's Here: the Only Stock Screener You'll Ever Need Get Started

Wall Street Regains Momentum on Vaccine Hopes: 5 Top Picks

By Zacks Investment ResearchStock MarketsNov 17, 2020 07:38AM ET
www.investing.com/analysis/wall-street-regains-momentum-on-vaccine-hopes-5-top-picks-200544879
Wall Street Regains Momentum on Vaccine Hopes: 5 Top Picks
By Zacks Investment Research   |  Nov 17, 2020 07:38AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
US2000
+1.05%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
GM
+2.17%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
LLY
+1.64%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
PFE
0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
IXIC
+1.28%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
IIVI
+2.12%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Wall Street has regained momentum in November after facing severe volatility in the last two months. Notably, U.S. stock markets witnessed an astonishing rally from April to August, terminating the coronavirus-led short bear market. However, resurgence of coronavirus cases, uncertainty regarding a fresh fiscal stimulus and election-related volatilities resulted in market turmoil in September and October.

However, encouraging news on the COVID-19 treatment front and hopes of a vaccine in the near future has significantly strengthened market participants' confidence in risky assets like equities. Investment in momentum stocks with a favorable Zacks Rank may be fruitful in the near term.

Wall Street Surges on Vaccine Hopes

On Nov 9, Pfizer Inc. (NYSE:PFE) PFE and BioNTech SE (NASDAQ:BNTX) BNTX announced that their jointly developed potential vaccine BNT162b2 was more than 90% effective in late-stage study. On Nov 10, the FDA granted emergency authorization to a COVID-19 antibody treatment made by Eli Lilly & Co. LLY. On Nov 16, Moderna (NASDAQ:MRNA) Inc. MRNA reported that its preliminary phase III clinical trial data showed that its potential coronavirus vaccine is more than 94% effective in preventing COVID-19.

The three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — have rallied 13%, 10.9% and 9.3%, respectively, month to date. Year to date, these three indexes have recorded gains of 5%, 12.3% and 32.9%, respectively.

On Nov 16, the Dow recorded a fresh closing high since Feb 12 and an all-time high since Nov 9. The S&P 500 posted its 24th closing high this year so far. The cyclical and reopening stocks have been major beneficiaries.

Moreover, the small-cap specific Russell 2000 and the S&P 600 have rallied 16.1% and 17%, respectively, month to date. On Nov 13, the Russell 2000 registered a fresh high since August 2018 and on Nov 16, the index touched an all-time high.

Indexes Post Fastest Recovery From Pandemic-Led Bear Market

The Dow entered coronavirus-induced bear market on Mar 9 and both the S&P 500 and the Nasdaq Composite fell into a bear market on the next day. A bear market is characterized as a decline of 20% in any asset's value from its recent high level. These three indexes registered bear market low on Mar 23.

It took 193 trading days for the Dow to record a fresh all-time closing high from its last bear market low, marking the fastest rebound of the blue-chip index since Apr 17, 1991. Meanwhile, the S&P 500 achieved this target in 126 trading days on Aug 18, reflecting its fastest such recovery. The Nasdaq Composite achieved this in just 76 trading days on Jun 8, its quickest rebound from a bear market low since March 2009.

Till Nov 16, the Dow, the S&P 500 and the Nasdaq Composite rose 64.4%, 65.5% and 79.8%, respectively, from their low levels recorded on Mar 23.

Our Top Picks

We have narrowed down our search to five momentum stocks. All these stocks witnessed robust earnings estimate revisions in the past seven 7 days reflecting solid near-term business prospects. These stocks have risen more than 15% month to date. Each of our picks carries a Zacks Rank #1 (Strong Buy) and has a Momentum Score of A. You can see the complete list of today’s Zacks #1 Rank stocks here.

The chart below shows the price performance of our five picks month to date.

Fulgent Genetics (NASDAQ:FLGT) Inc. FLGT is a medical technology company that provides genetic testing services to physicians with clinically actionable diagnostic information. The Zacks Consensus Estimate for the current year has improved more than 100% over the past seven days. The stock price has soared 41.5% month to date.

II-VI (NASDAQ:IIVI) Inc. IIVI develops, manufactures, and markets engineered materials, and optoelectronic components and devices worldwide. It operates through three segments, II-VI Laser Solutions, II-VI Photonics, and II-VI Performance Products. The Zacks Consensus Estimate for the current year has improved 3.7% over the past seven days. The stock price has jumped 32.5% month to date.

General Motors Co. 's GM strong demand for profitable trucks and SUVs is aiding the company's revenues. Its hot-selling brands in the United States like Chevrolet Silverado, Equinox and GMC Sierra are also driving the top line. The Zacks Consensus Estimate for the current year has improved 9% over the past seven days. The stock price has climbed 22% month to date.

Flagstar Bancorp (NYSE:FBC) Inc. FBC operates as a savings and loan holding company for Flagstar Bank that provides commercial and consumer banking services to individuals and businesses in the United States. The Zacks Consensus Estimate for the current year has improved 0.3% over the past seven days. The stock price has risen 17.9% month to date.

Lear (NYSE:LEA) Corp. LEA designs, develops, engineers, manufactures, assembles and supplies automotive seating, electrical distribution systems and related components for automotive original equipment manufacturers in North America, Europe, Africa, Asia, South America and internationally. The Zacks Consensus Estimate for the current year has improved 4.3% over the past seven days. The stock price has advanced 16.6% month to date.

Legal Marijuana: An Investor’s Dream

Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.

Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.

Download Marijuana Moneymakers FREE >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Pfizer Inc. (PFE): Free Stock Analysis Report

Moderna, Inc. (MRNA): Free Stock Analysis Report

General Motors Company (NYSE:GM): Free Stock Analysis Report

Eli Lilly and Company (NYSE:LLY): Free Stock Analysis Report

IIVI Incorporated (IIVI): Free Stock Analysis Report

Lear Corporation (LEA): Free Stock Analysis Report

Flagstar Bancorp, Inc. (FBC): Free Stock Analysis Report

Fulgent Genetics, Inc. (FLGT): Free Stock Analysis Report

BioNTech SE Sponsored ADR (BNTX): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research
Wall Street Regains Momentum on Vaccine Hopes: 5 Top Picks
 

Related Articles

Wall Street Regains Momentum on Vaccine Hopes: 5 Top Picks

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email